Morrison Foerster is an international law firm with lawyers practicing throughout the United States, Asia, and Europe. Click to discover more.

mofo_share_image.jpg

Morrison Foerster

common-default.jpeg

Terms / Notices

Cookies

Privacy Policy

Reporting Hotline

Attorney Advertising

Alumni

  Linkedin

MoFo LinkedIN

  Facebook

MoFo Facebook

YouTube

MoFo Youtube

Morrison Foerster - Footer

Morrison Foerster Recognized by Law Society of Hong Kong with Silver Law Firm Award

You have not solved the recaptcha challenge yet or session expired, try again.

Email Disclaimer

Disclaimer

Unsolicited e-mails and information sent to Morrison Foerster will not be considered confidential, may be disclosed to others pursuant to our <a href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>, may not receive a response, and do not create an attorney-client relationship with Morrison Foerster. If you are not already a client of Morrison Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

Feedback

mofo-logo-2022.svg

People

Capabilities

Resources

About

Community

Offices

Careers

Stay Connected

The Law Society of Hong Kong has honored Morrison Foerster with the Silver Law Firm Award as part of its 2022 Pro Bono and Community Work Recognition Programme. It is a testament to the firm’s outstanding commitment to pro bono and community work.

<h3>Sorry, we weren’t able to find the terms you entered.</h3>Please try a different term or keyword.

People

Capabilities

Resources

Not Found Cards

About Morrison Foerster

people-default-header-desktop.jpg

people-default-header-mobile.jpg

Default Meta Data

The Law Society of Hong Kong has honored Morrison Foerster with the Silver Law Firm Award as part of its 2022 Pro Bono and Community Work Recognition Programme. It is a testament to the firm’s outstanding commitment to pro bono and community work.At the individual level, eight lawyers from the firm’s Hong Kong and Beijing offices received recognitions for their continued pro bono efforts, including:<ul><li>Zooey Chen, Associate – Silver</li><li>Tyler Xiu, Associate – Silver</li><li>Sarah Luo, Associate – Bronze</li><li>Timothy Blakely, Managing Partner – Bronze</li><li>Paul McKenzie, Managing Partner – Bronze</li><li>Stephen Birkett, Senior Consultant – Bronze</li><li>Gary Zeng, Of Counsel – Bronze</li><li>Yilong Luo, Associate – Bronze</li></ul>Lawyers at Morrison Foerster live out the firm’s proud pro bono tradition every day. Their work runs the gamut, from counseling hundreds of nonprofit organizations and social enterprises on legal needs to individual advocacy for people who otherwise would be shut out from access to justice. View more information on our <a href="/culture/pro-bono" target="_self">Pro Bono</a> page.The Law Society of Hong Kong Pro Bono and Community Work Recognition Programme was launched in January 2010 with the aim to promote and encourage the Law Society members to actively participate in pro bono and community work.

Morrison Foerster Recognized by Law Society of Hong Kong with Silver Law Firm Award

Sign Up

Zhiyu (Zooey)’s practice focuses on technology transactions, data privacy, and regulatory compliance advisory work. She has experience performing due diligence on data, cybersecurity, and intellectual property issues in M&A and private equity investments.Prior to joining Morrison Foerster, Zooey was a trainee solicitor in the London and Hong Kong offices of a leading international law firm.Zooey is a Registered Foreign Lawyer with the Law Society of Hong Kong. She is native in Mandarin and fluent in English.<h4>Representative Experience</h4><ul><li>A leading Singapore-based investment management company on its investment in a leading data-based searching company in China.</li><li>A leading online payment platform on its data processing, privacy policies, and personal information protection issues.</li><li>A Chinese state-owned telecommunications enterprise on its potential risk control issues in relation to the GDPR.</li><li>A leading multinational hospitality group on its responses to regulators in Asia (Hong Kong, Australia, Japan, Korea, and PRC) in relation to its data breaches investigations.</li><li>Leading multinational automotive manufacturing companies on various PRC law issues in relation to its automated driving systems, radio equipment and other in-car information services.</li></ul>*Including work performed at prior firms.

陈志瑜律师的执业领域主要是针对技术交易、数据隐私和监管合规事宜提供法律意见。她在就并购和私募股权投资项目中所涉及的数据、网络安全和知识产权问题开展尽职调查方面拥有丰富的经验。在加入美富之前，陈律师是一家领先的国际律所伦敦和香港办事处的实习律师。陈律师通晓普通话和英语。她是香港律师会注册外国律师。<h4>具有代表性的交易</h4><ul><li>一家领先的新加坡投资管理公司处理其向一家领先的中国数据检索公司进行投资事宜。</li><li>一家领先的在线支付平台处理数据处理、隐私政策以及个人信息保护问题。</li><li>一家中国国有电信企业处理与《通用数据保护条例》有关的潜在风险控制问题。</li><li>一家领先的跨国酒店集团处理针对数据违约调查事宜向亚洲国家及地区（包括香港、澳大利亚、日本、韩国和中国）监管机构做出响应。</li><li>领先的跨国汽车制造公司处理与自动驾驶系统、无线电设备和其他车内信息服务有关的各种中国法律问题。</li></ul>*包括在之前律所开展的工作

Zooey Chen

Associate

Tyler’s practice encompasses various aspects of transactional, regulatory, and contentious IP matters including technology transfer and licensing, IP and data-driven strategic cooperation, technical services and outsourcing arrangements, technology/IP-related advice in cross-border M&A and PE transactions, cybersecurity and data privacy, telecommunications regulation, pharmaceutical regulation, and patent protection. He advises a diverse range of multinational companies mainly in the life sciences, IT, telecommunications, manufacturing, and financial industries. In the words of his clients, “Tyler Xiu is an excellent up-and-coming lawyer, who is very proactive and helpful.” (The Legal 500 Asia Pacific).Tyler is fluent in Chinese and English.<h4>Representative Experience</h4><ul><li>CPE, a Chinese alternative investment firm, in connection with its US$350 million joint venture with Restaurant Brands International (RBI), one of the world's largest multinational fast food holding company, to operate Burger King in China which has around 1,250 restaurants in total. This transaction is one of the most significant private equity-led transactions in China’s consumer sector in 2025.</li></ul><ul><li>Advising Ensem Therapeutics, Inc., a biotechnology company focusing on high value and difficult-to-drug oncology targets, on its partnership with BeiGene, Ltd., a global biotechnology company, for BeiGene to acquire an exclusive global license to an Investigational New Drug (IND) application-ready oral cyclin-dependent kinase 2 (CDK2) inhibitor. Under the terms of the agreement, ENSEM will receive an upfront payment, and will be eligible for additional payments upon the achievement of certain development, regulatory, and commercial milestones, totaling up to $1.33 billion, in addition to tiered royalties.</li><li>Advising Jamieson Laboratories Ltd. and its parent company Jamieson Wellness Inc. (TSX:JWEL) in their partnership with DCP Capital, a leading international private equity firm founded by experienced private equity investors in Greater China. Through this transaction, DCP contributed US$35 million in exchange for a 33% interest in the Company’s Chinese operations and made a US$75 million preferred share investment in the Company.</li><li>Counseling a U.S. medical device company that focuses on the research, development, production, and marketing of respiratory care devices and services, in its engagement by a PRC medical device company for commissioned development of automatic high flow ventilators, including the associated technology licensing arrangements.</li><li>Advising a U.S. biopharmaceutical company on its strategic collaboration with a Chinese pharmaceutical company to develop and commercialize a bi-functional fusion protein inhibiting immune checkpoint and activating natural killer (NK) cells for the treatment of solid tumors, in the Asia Pacific Ex-Japan region.</li><li>Advising a leading pan-Asian retailer in Hong Kong on:<ul><li>A technology license agreement and joint venture with a digital retail platform for the purposes of providing online retailers with operational processes, marketing, supply, payment, merchandise, e-commerce, and customer services; and</li><li>Its licensing of technology and trademarks and provision of technical services in relation to the establishment of a joint venture for the purposes of developing a market-leading independent multi-partner coalition loyalty program for the ASEAN markets, and also the data privacy and data security issues under PRC law and cross-border data transfer issues that involve multiple jurisdictions in Asia. </li></ul></li><li>Advising an online game platform and game creation system on its trailblazing joint venture with another company to establish and launch the game platform in China, which would be the first foreign online game platform with user-generated games and revenue-sharing to obtain a government license in the PRC. </li><li>Advising a leading Chinese investment fund on its strategic partnership with a leading U.S. IT software company to establish the financial cloud infrastructure for the People’s Bank of China, key state banks, and the governments of various major cities.</li><li>Assisting a leading global digital library with the amendment of its license agreement with a Chinese Internet technology company, under which the tech company is granted a license to allow users to access the client’s digital library of sheet music.</li><li>Advising a PRC advanced semiconductor materials company on obtaining a technology license and associated support services from a German specialty chemicals and equipment company, with respect to chemicals for wafer level packaging and wafer level semiconductor interconnect.</li></ul>

修徇泽律师擅长处理知识产权项目所涉及的交易、监管、争议解决等多个层面的法律问题，包括技术转让和许可、知识产权及数据驱动的战略合作、技术服务和外包、跨境并购/私募股权交易所涉及的技术及知识产权问题、网络安全及数据隐私保护、电信监管，药品监管、以及专利保护等。修律师主要为生命科学、信息技术、电信、制造和金融行业的跨国客户提供法律意见。客户曾如此评价他：“修律师是一位崭露头角的出色律师，他非常积极主动，提供富有成效的建议。”（《亚太法律500强》）修律师精通中英文。<h4>具有代表性的项目 </h4><ul><li>代表中国另类投资公司CPE源峰就其与世界上最大的餐饮公司之一餐饮品牌国际集团（Restaurant Brands International，简称 RBI）成立价值3.5亿美元的合资企业。该合资企业将负责汉堡王在中国的运营，目前在全国拥有约 1,250 家餐厅。本次交易是 2025 年中国消费行业中由私募股权基金主导的最具代表性交易之一。</li></ul><ul><li>代表聚焦肿瘤治疗领域高价值、难成药靶点的生物科技公司昂胜医药(Ensem Therapeutics, Inc.)达成一项与全球生物科技公司百济神州(BeiGene, Ltd.)的授权合作协议。百济神州将获得一款在研、即将提交新药临床试验(IND)申请的口服细胞周期蛋白依赖性激酶2(CDK2)抑制剂的全球独家许可权利。根据协议条款，昂胜将获得一笔首付款，并基于取得的特定研发、注册和商业化里程碑，有权获得至多13.3亿美元的总交易额款项，以及分级销售特许使用费。</li><li>代表Jamieson Laboratories Ltd.及其母公司健美生公司（多伦多证券交易所：JWEL）处理其与DCP Capital达成合作的事宜。DCP Capital是一家由大中华区经验丰富的私募股权投资者所创立的领先的国际私募股权公司。通过本次交易，德弘出资3500万美元，获得该公司中国业务33%的权益，并以优先股形式对该公司进行7500万美元的投资。</li><li>代表一家专注于研究、开发、生产和销售呼吸护理设备和服务的美国医疗设备公司处理其受一家中国医疗设备公司委托开发自动高流速呼吸机的事宜，包括相关的技术许可安排。</li><li>代表美国某生物制药公司与一家中国制药公司进行战略合作，在除日本外的亚太地区开发和商业化一种抑制免疫检查点和激活自然杀伤细胞治疗实体瘤的双功能融合蛋白的事宜。</li><li>代表一家位于香港的领先的泛亚洲零售商： </li><ul><li>处理其与一家数字零售平台签订技术许可协议并成立合资企业，为在线零售商提供运营流程、营销、供应、支付、商品、电子商务和客户服务；以及</li><li>成立一家合资企业，并向该合资企业授权技术和商标并提供技术服务，以便在东盟市场开发市场领先的独立多合作伙伴联盟忠诚度计划。同时处理涉及中国法律规定的数据隐私和数据安全问题，以及涉及亚洲多个司法管辖区的跨境数据传输问题。</li></ul><li>代表一家网络游戏平台和游戏创作系统公司处理其与另一家公司成立合资企业，在中国建立并推出游戏平台，该游戏平台将成为首个在中国获得政府许可的用户生成游戏和收入共享的外国网络游戏平台。</li><li>代表一家领先的中国投资基金处理其与一家领先的美国IT软件公司建立战略合作伙伴关系，为中国人民银行、主要国有银行和各大城市政府建立金融云基础设施。</li><li>代表某全球领先的乐谱数字图书馆处理其与某中国互联网科技公司修改许可协议的事宜。依据该许可协议，该科技公司被授予许可允许其用户访问乐谱数字图书馆。</li><li>代表一家中国先进的半导体材料公司处理其从一家德国特殊化学品和设备公司获得技术许可和相关支持服务的事宜，其中涉及晶圆级封装和晶圆级半导体互连的化学品。</li></ul>

Tyler Xiu

Of Counsel

Tim is a partner in Morrison Foerster’s Securities Litigation and Investigations + White Collar Defense groups. His practice focuses on government and internal investigations and complex commercial litigation and international arbitration matters. He is the former managing partner of the Hong Kong office.With more than 20 years of experience in the U.S. and Asia, Tim represents companies and individuals in complex dispute-related matters, including government and internal investigations, regulatory proceedings, securities class action lawsuits, international arbitrations, and other complex litigation mandates. He has represented multinational and Chinese clients in various industries, including telecommunications, biotechnology, publishing, pharmaceuticals, and financial services. Tim is a member of the firm’s FCPA + Global Anti-Corruption and Global Ethics + Compliance teams. Tim has practiced in New York, California, and Hong Kong, handling fraud, misrepresentation, breach of contract, securities litigation, investment disputes, commercial arbitration, and enforcement-related matters – from inception through trial. His practice has a strong U.S. and Asia nexus, and he regularly advises clients facing cross-border disputes and enforcement actions, often involving the laws of multiple jurisdictions.As a Hong Kong solicitor, Tim has been instructed by clients in key contentious proceedings and arbitration-related matters before Hong Kong courts (including the Court of First Instance, the Court of Appeal, and the Court of Final Appeal), as well in proceedings with Hong Kong regulators and statutory tribunals. He has advised clients in investigations by Hong Kong law enforcement regulators including the Securities & Futures Commission and the Customs & Excise Department, among others. He regularly acts for clients in Hong Kong-seated international arbitration proceedings.

Timothy Blakely律师是美富律师事务所证券诉讼与调查以及白领犯罪辩护业务组的合伙人。他的执业领域主要专注于政府调查和内部调查，以及复杂商业诉讼和国际仲裁事务。他曾担任香港办公室的管理合伙人。Blakely律师在美国及亚洲拥有超过20年的执业经验，代表公司及个人处理各类复杂争议相关事宜，包括政府及内部调查、监管程序、证券集体诉讼、国际仲裁及其他复杂诉讼事务。他曾为来自电信、生物技术、出版、医药及金融服务等多个行业的跨国公司及中国客户提供法律服务。Blakely律师亦是本所美国《反海外腐败法》（FCPA）及全球反腐败工作组，以及全球道德与合规工作组的成员。Blakely律师曾在纽约、加州及香港执业，处理欺诈、不实陈述、合同违约、证券诉讼、投资争议、商业仲裁及执行相关事宜，其工作贯穿案件从初始阶段至审判全过程。他的执业实践与美国及亚洲均有紧密联系，经常就涉及多个司法管辖区法律的跨境争议及执法行动向客户提供法律意见。作为一名拥有香港事务资格的律师，Blakely律师曾受客户委托，在香港各级法院（包括原讼法庭、上诉法庭及终审法院）处理重要争讼程序及仲裁相关事宜，并代表客户在香港监管机构及法定特别法庭处理相关程序。他曾就香港执法及监管机构（包括证券及期货事务监察委员会及香港海关等）所进行的调查向客户提供法律意见，并经常代表客户处理以香港为仲裁地的国际仲裁程序。

Timothy Blakely

Partner

Paul has more than 30 years’ experience advising leading international companies on complex transactional and other business law matters in China and elsewhere in Asia.He advises Fortune 100 and other global companies pursuing M&A, joint venture, and other corporate transactions, bringing to his work a deep understanding of the regulatory environment in China and a sensitivity to cultural issues in Asia. Paul also helps clients navigate China’s complex and changing regulatory environment, advising on a broad range of issues such as data privacy and security, industry permitting, and anti-corruption compliance. Paul is a member of the firm’s market-leading global data, cyber and privacy group and a recognized expert on China’s emerging data regulatory regime. He works across a broad range of industries, including information technology, real estate, chemicals and energy, and natural resources.Paul is a fluent Mandarin speaker and has written widely on issues related to Chinese law.He serves on the board of directors of The Morrison & Foerster Foundation, the firm’s charitable foundation.

麦保罗（Paul McKenzie）律师在代表领先的国际公司处理中国和其他亚洲地区的复杂交易和其他商业法律事宜方面拥有超过30年的经验。麦保罗律师代表财富100强企业和其他全球公司处理并购、合资和其他公司交易事宜，同时将他对中国监管环境的深入了解，以及对亚洲文化问题的敏锐运用于其中。他还帮助客户应对中国复杂且不断变化的监管环境，并就各类问题（例如数据隐私与网络安全，行业许可和反腐败合规）提供咨询。麦保罗律师还是本所市场领先的全球隐私和数据安全业务组的成员之一，也是中国新兴数据监管制度领域公认的业内专家。麦保罗律师的业务涉及广泛的行业，包括信息技术，房地产，化学品，能源和自然资源。他精通汉语，并针对中国法律的相关问题广泛撰文。麦保罗律师是本所的慈善基金 “美富基金会”的董事会成员。

Paul McKenzie

Stephen Birkett is a Senior of Counsel at the firm and a Partner in our Hong Kong office.Stephen has practiced in Hong Kong for over 25 years and specializes in capital markets advisory and transactional matters, regulatory issues, and mergers and acquisitions transactions. His experience includes advising on the Hong Kong Stock Exchange Listing Rules, including numerous IPOs, and the Hong Kong Takeovers Code, as well as corporate and securities law and regulations generally. This includes advising clients on SFC licensing issues for intermediaries, non-contentious employment matters, and general commercial transactions.He recently advised a securities fintech business licensed by the SFC and which offers a Chinese language app for trading equities in select international markets on SFC compliance issues.Prior to joining Morrison & Foerster, Stephen served for three years as Senior Director of Corporate Finance with the Securities and Futures Commission in Hong Kong. Before that, he was a partner and Head of Corporate Finance in a leading international firm in Hong Kong. He was a member of the Hong Kong Government Standing Committee on Company Law Reform from 2011 until the end of his six-year tenure.Stephen is a frequent speaker at conferences on Hong Kong securities legal issues and has authored chapters on the Hong Kong Takeovers Code and Listing Rules in the popular “Practitioner’s Guide” series.Stephen is fluent in French and Spanish.

白士文律师在香港的执业时间已超过25年，专门处理资本市场咨询和交易事宜、监管问题以及并购交易。他的经验包括就《香港联交所上市规则》提供法律意见，其中涉及多次首次公开发行、《香港收购守则》以及一般公司及证券法律法规事宜。他曾就中间机构获取证监会牌照事宜、无争议性雇佣事宜以及一般商业交易提供法律意见。在加入美富之前，白律师担任香港证券及期货事务监察委员会（证监会）的高级董事三年。之前亦曾经担任香港一家具领导地位的国际律师事务所的合伙人及企业融资部门主管。白律师从2011年起出任香港公司法改革常务委员会的成员，直至其六年任期期满为止。白律师经常就香港证券的法律问题发表演说，并且曾经撰写广受欢迎的“执业者指引”（Practitioner’s Guide）系列中有关《香港收购守则》及《上巿规则》的章节。白律师精通法语和西班牙语。

Stephen Birkett

Solicitor

Gary’s practice focuses on investigation and dispute resolution matters for multinational and Asia-based companies. Gary has extensive experience in investigating allegations of corruption, fraud, conflict of interest, and other business misconduct in various industries including IT, finance, medical products, real estate, and manufacturing. He frequently assists multinational investors in pre-investment anti-corruption due diligence reviews of investments in China and other jurisdictions, as well as regulatory risk assessments of China business operations.   Gary also advises multinational companies in negotiating and litigating China-related business disputes. His experience includes assisting clients in connection with disputes arising out of Sino-foreign joint ventures, private antitrust enforcement, intellectual property, complex commercial contracts, and other business matters. In addition, he has extensive experience in assisting multinational companies in coordinating responses to Chinese regulatory inquiries.Gary is a Registered Foreign Lawyer with the Law Society of Hong Kong. Fluent in English, Mandarin, and Cantonese, he once worked as an in-house counsel for a major Fortune 500 company, advising on various contentious and regulatory matters in China.<h4>Representative Experience</h4><h5>Investigation/compliance</h5><ul><li>U.S. technology company in internal investigation of potential FCPA and corruption issues in China involving interactions with third party business consultants and Chinese government officials.</li><li>U.S. technology company in internal investigation of alleged bribery and fraudulent practices of senior management in China relating to sale of IT products through government procurement bids. </li><li>U.S. semiconductor company in internal investigation of potential FCPA and corruption issues in China, the U.S., and Europe involving cooperation with third party business consultants and interaction with Chinese state-owned enterprises.</li><li>Former senior executive of a major international investment bank in U.S. government investigations into hiring practices in Asia.</li><li>U.S. medical device company in M&A due diligence review of a China-based medical device company concerning anti-corruption internal controls and compliance with the FCPA and PRC anti-corruption laws.</li><li>Major U.S. private equity firm in pre-transaction FCPA and anti-corruption due diligence related to investment in a commercial real estate business in China. </li><li>Major international consulting company in M&A due diligence review of China-based companies concerning anti-corruption, internal controls, and compliance with PRC competition laws.</li><li>Two major international chemical companies in China compliance matters concerning environmental protection, product import, work safety, and other regulatory areas.  </li><li>Hong Kong listed Chinese companies in response to enquiries from Hong Kong regulatory authorities concerning operational and financial issues in mainland China. </li></ul><h5>Dispute Resolution</h5><ul><li>U.S. software company in a private anti-monopoly litigation alleging abuse of market dominance brought by former business partner in a PRC court.</li><li>Major Japanese chemical company in a Sino-foreign equity joint venture dispute with a Chinese SOE group concerning two joint venture companies in China. </li><li>U.S. technology company in connection with PRC court proceedings against Chinese distributor arising out of distribution of electrical equipment.</li><li>Leading Chinese financial database company in shareholder dispute and intellectual property-related dispute with U.S.-based minority shareholders.  </li><li>U.S. software company in a dispute with its China distributor and related internal investigation of alleged misconduct by the software company’s China managers.</li><li>U.S. software company in a computer software copyright infringement action against a Chinese company in a PRC court. </li><li>Major Chinese telecom company in a contractual dispute with business partners in the U.S. and China concerning complex telecom service contract performance issues.</li></ul>

曾宇律师的执业领域主要是为国际和亚洲公司处理与中国相关的调查和争议解决事宜。曾律师在处理调查事宜方面拥有丰富的经验，涉及反腐败、欺诈和其他业务不当行为主张的调查以及涉及信息技术、金融和制造等行业的调查。曾律师在协助跨国公司与中国监管机构的协调，并针对该类机构的质询做出答复以及处理其他争议及诉讼事宜方面也拥有丰厚的经验。他还拥有开展与合规问题相关的尽职调查工作的经验。在其职业生涯早期，曾律师在一家大型《财富500强》公司的中国公司担任两年多公司法律顾问。在担任公司法律顾问期间，针对各种争议和监管事宜提供法律意见。曾律师精通英语、粤语和普通话。他是香港律师会注册外国律师。

Gary Zeng

Yilong’s practice focuses on mergers and acquisitions, private equity investments, as well as other general corporate matters.Yilong received a J.D. cum laude from Cornell Law School in 2017, where he was a notes editor of the Cornell Law Review.Yilong is a Registered Foreign Lawyer with the Law Society of Hong Kong. Prior to joining MoFo, he practiced in New York and London as an associate of two leading international firms. He is fluent in Mandarin and English.<h4>Representative Experience:</h4><ul><li>A leading private equity firm in its US$500 million partnership with Temasek, including Temasek taking a minority stake in the client, and a multi-fund investment by Temasek to anchor the client’s future funds.</li><li>A special purpose acquisition company in its US$300 million initial public offering and subsequent search for acquisition opportunities.</li><li>A U.S.-based pharmaceutical company in an up-C merger with Amneal Pharmaceuticals (NYSE: AMRX).</li><li>A leading private equity firm in its fund’s divestment of the majority of its holding in Orchid Orthopedic Solutions to Nordic Capital Fund IX.</li><li>A London-based family office in its strategic minority investments in EagleTree Capital.</li></ul>

罗亦龙律师的业务主要侧重于收购合并、私募股权投资，以及其他一般公司事宜。罗律师于2017年获得康奈尔大学法学院的法律博士学位，并以优等成绩毕业。他曾担任《康奈尔法律评论》的笔记编辑。罗律师是香港律师会注册外国律师。在加入美富前，罗律师曾分别在纽约与伦敦的两所顶尖国际律所担任律师。罗律师精通普通话与英语。<h4>具有代表性的项目：</h4><ul><li>代表某领先的私募股权公司处理其与淡马锡之间的5亿美元合作事宜，包括淡马锡收购其少数股权，以及淡马锡对多只基金作出投资，从而成为其未来基金的锚定投资者。</li><li>代表某特殊目的收购公司处理其3亿美元的首次公开发行，以及其后物色收购机会的事宜。</li><li>代表某位于美国的制药公司处理其与Amneal Pharmaceuticals（纽交所：AMRX）作出UP-C合并的事宜。</li><li>代表某领先的私募股权公司处理其设立的基金将其大部分Orchid Orthopedic Solutions的股权剥离并售予Nordic Capital Fund IX的事宜。</li><li>代表某位于伦敦的家族办公室处理其对EagleTree Capital作出战略性少数股权投资的事宜。</li></ul>